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Assigning functions to newly discovered genes constitutes one of the major challenges en route to fully
exploiting the data becoming available from the genome sequencing initiatives. Heterologous expression in an
appropriate host is central in functional genomics studies. In this context, filamentous fungi offer many
advantages over bacterial and yeast systems. To facilitate the use of filamentous fungi in functional genomics,
we present a versatile cloning system that allows a gene of interest to be expressed from a defined genomic
location of Aspergillus nidulans. By a single USER cloning step, genes are easily inserted into a combined
targeting-expression cassette ready for rapid integration and analysis. The system comprises a vector set that
allows genes to be expressed either from the constitutive PgpdA promoter or from the inducible PalcA
promoter. Moreover, by using the vector set, protein variants can easily be made and expressed from the same
locus, which is mandatory for proper comparative analyses. Lastly, all individual elements of the vectors can
easily be substituted for other similar elements, ensuring the flexibility of the system. We have demonstrated
the potential of the system by transferring the 7,745-bp large mpaC gene from Penicillium brevicompactum to A.
nidulans. In parallel, we produced defined mutant derivatives ofmpaC, and the combined analysis of A. nidulans
strains expressing mpaC or mutated mpaC genes unequivocally demonstrated that mpaC indeed encodes a
polyketide synthase that produces the first intermediate in the production of the medically important immu-
nosuppressant mycophenolic acid.
Filamentous fungi have the ability to produce a plethora of
bioactive metabolites and enzymes enabling them to thrive in
competitive environments. Among the metabolites are not
only mycotoxins but also compounds that are used as drugs,
e.g., the antibiotic penicillin and the immunosuppressant my-
cophenolic acid (MPA). Since many of the desirable products
are naturally secreted in large amounts, fungi possess consid-
erable potential as expression hosts for the production of small
molecules as well as proteins. The wide interest in fungi has led
to the sequencing of an increasing number of fungal genomes,
and this number is expected to increase dramatically in the
coming years (30). This resource constitutes a tremendous
potential for future advances in the basic understanding and
industrial exploitation of fungal biology. For example, the
number of gene clusters predicted to produce secondary me-
tabolites, such as polyketides and nonribosomal peptides, con-
stantly increases as new fungal genome sequences are released.
However, at present, the compound produced by the enzymes
encoded by the gene cluster has been identified for only a few
of these gene clusters. Since for most organisms no or ineffi-
cient gene-targeting technology exists, it is often difficult to
assign secondary metabolites to specific genes in the natural
host. This problem can be solved by transferring genes of
interest to a suitable heterologous host that can provide a wide
range of genetic tools for gene characterizations. Considering
the large number of genes to be analyzed, it is important to
develop high-throughput methods that facilitate this process.
Preferentially, the foreign gene should be expressed from a
defined, well-characterized location. Compared to random in-
tegration, this provides several advantages. First, integration at
a random site may cause mutation or alter expression of neigh-
boring genes, causing unpredictable pleiotropic effects (3).
Second, since integrated genes are differentially expressed, de-
pending on the genomic context at the site of integration, it
eliminates undesired positioning effects by ensuring that the
novel genes are integrated at a location that accommodates a
high expression level (29). Third, it allows for comparative
studies where the phenotypes of strains expressing wild-type
and mutated alleles can be reliably compared, as the gene
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variants are expressed from the same locus in the different
strains.
Aspergillus nidulans serves as a widely used model for fila-
mentous fungi and has been extensively used for basic genetic
research. Many genetic tools are therefore available, including
efficient gene targeting in strains where the nonhomologous
end-joining pathway for DNA integration has been eliminated
(14, 16, 17). However, compared to the yeast Saccharomyces
cerevisiae (where only 20 to 50 bp are needed), gene-targeting
substrates need to contain large, 1,500-bp, homologous se-
quences to ensure integration at the selected locus. Accord-
ingly, a gene-targeting substrate that contains an expression
cassette and a selectable marker is constructed from six pieces
of DNA and often exceeds a total size of 10 kb, complicating
its construction (Fig. 1). Construction of gene-targeting sub-
strates therefore constitutes a potential bottleneck in a high-
throughput gene analysis process.
Here we present a vector set based on the USER (uracil-
specific excision reagent) cloning technique, which allows rapid
and easy generation of constructs for targeted integration and
heterologous expression of a gene of interest in A. nidulans. As
a proof of concept, the vector set was used to express the
heterologous mpaC gene from Penicillium brevicompactum
(see the accompanying manuscript in this issue by Regueira et
al. [25]). mpaC is located in a gene cluster predicted to encode
the biosynthetic enzymes for the production of the immuno-
suppressant mycophenolic acid. By analyzing A. nidulans
strains that express mpaC under the control of both constitu-
tive and inducible promoters, as well as constitutive expression
of a point-mutated mpaC, we conclusively show that MpaC
catalyzes the production of 5-methylorsellinic acid (5-MOA),
the first intermediate in mycophenolic acid production.
MATERIALS AND METHODS
Strains and media. The A. nidulans strains IBT28738 (argB2 veA1 pyrG89
nkuA-trS::AFpyrG) and IBT29539 (argB2 veA1 pyrG89 nkuA) (17) were used
for strain constructions when argB or pyrG was used as selection marker, respec-
tively. The IBT30750 strain (veA1 pyrG89), NID127, was used as reference strain
in growth experiments. A full list of A. nidulans strains is provided in Table 1. All
plasmids were propagated in Escherichia coli strain DH5. Minimal medium
(MM) contained 1% glucose, 10 mM NaNO3, 1 salt solution (4), and 2% agar
for solid media. MM was supplemented with 10 mM uridine (Uri), 10 mM uracil
(Ura), and 4 mM L-arginine (Arg) when necessary. Solid plates containing
5-fluoroorotic acid (5-FOA; Sigma-Aldrich) were made as MM plus Uri and Ura
medium supplemented with filter-sterilized 5-FOA to a final concentration of 1.3
mg/ml. YES medium (yeast extract-sucrose) was made as previously described
(9) and supplemented with 10 mM Uri, 10 mM Ura, and 4 mM Arg when
necessary. PalcA induction medium consisted of 100 mM L-threonine, 100 mM
glycerol, 10 mM NaNO3, mineral mix (1), 2 g agar/liter. PgpdA::lacZ activity
was determined on MM supplemented with 0.122 mM 5-bromo-4-chloro-3-
indolyl-beta-D-galactopyranoside (X-Gal), 10 mM uracil, and 10 mM uridine.
PCR and USER cloning. Amplification of DNA by PCR to produce DNA
fragments suitable for USER cloning was performed in 30 PCR cycles using the
proofreading PfuTurbo Cx Hotstart polymerase (Stratagene) or PfuX7 (21) in 50
l according to the manufacturer’s instructions. USER cloning was performed as
previously described (22) with minor modifications. The USER vectors were
digested for 6 h with AsiSI for the AsiSI/Nb.BsmI and AsiSI/Nb.BtsI USER
cassettes or PacI for the PacI/Nt.BbvCI USER cassettes A and B, followed by
digestion with the appropriate nicking endonuclease for 1 h. Purified digested
vector (0.1 pmol) was mixed with 1 pmol purified PCR products amplified with
primers that were extended by the appropriate tails for USER cloning into a
designated USER cassette (see Fig. S1, S2, S3, S4, and S5 in the supplemental
material). When more than one PCR product was cloned simultaneously, the
combined concentration of PCR product was kept at 1 pmol and the same
concentration of each PCR product was used. The DNA mix was adjusted to 8
l by adding Milli-Q purified water followed by addition of 1 l of 10 TE buffer
(100 mM Tris-HCl, 1 mM EDTA; pH 8.0) and 1 U of USER enzyme mix (New
England BioLabs). The reaction mixture was incubated for 20 min at 37°C,
followed by 20 min at 25°C. Next, the 10-l reaction mix was used directly to
transform chemically competent E. coli cells.
Construction of USER vectors. Four different USER cassettes were designed
to allow for the construction of the USER vector set: the two PacI/Nt.BbvCI
USER cassettes A and B (see Fig. S3 in the supplemental material) (8), one
AsiSI/Nb.BsmI USER cassette (see Fig. S1 in the supplemental material), and an
AsiSI/Nb.BtsI USER cassette (see Fig. S2 in the supplemental material). The
founder vector used to construct the USER vector set, pU0002, was custom
made by DNA2.0 (Menlo Park, CA). pU0002 is based on pJ204 and contains a
USER linker containing two successive PacI/Nt.BbvCI USER cassettes, A and B.
The USER linker is flanked by SwaI and NotI restriction sites on both sides. The
cloning strategies and cloning into the individual USER cassettes and vectors are
outlined in Fig. S1, S2, S3, S4, and S5 in the supplemental material. Sequences
and descriptions of primers used toward creating this vector set are found in
Tables S1 and S2 in the supplemental material.
Nomenclature for the USER vector set. Nomenclature for our USER vector
set follows the general system pU QXYZ-IS. Q describes the marker present in
the plasmid for use after A. nidulans transformation, with 0 indicating no marker,
1 indicating argB, 2 indicating AFpyrG (flanked by direct repeats to allow marker
excision), and 3 indicating ble (resistance to the genotoxin bleomycin). X denotes
which promoter is present in the plasmid, with 0 indicating no promoter, 1
indicating PgpdA, and 2 indicating PalcA. Y denotes which terminator is present
in the plasmid, with 0 indicating no terminator and 1 indicating TtrpC. Z is
defined by the USER cassettes that are present in the plasmid, with 0 indicating
no USER cassette, 1 indicating the AsiSI/Nb.BtsI casette, 2 indicating PacI/
Nt.BbvCI USER cassettes A and B, 3 indicating AsiSI/Nb.BtsI cassette and
PacI/Nt.BbvCI cassettes A and B, and 4 indicating AsiSI/Nb.BsmI cassette and
PacI/Nt.BbvCI cassettes A and B. An IS is present in the name of the plasmid if
a PCR fragment for targeting has been inserted into the PacI/Nt.BbvCI USER
cassettes A and B, with 1 indicating targeting regions for homologous recombi-
nation into insertion site 1 (IS1) are present.
TABLE 1. Names and descriptions of the strains used in this work
Strain Genotype
NID66 ................argB2 pyrG89 veA1 nkuA IS1::PalcA-mpaC-TtrpC-AFpyrG
NID127 ..............pyrG89 veA1
NID189 ..............argB2 pyrG89 veA1 IS1::PgpdA-mpaCD1622A-TtrpC-argB
NID190 ..............argB2 pyrG89 veA1 IS1::PgpdA-mpaCS1623A-TtrpC-argB
NID192 ..............argB2 pyrG89 veA1 IS1::PgpdA-lacZ-TtrpC-argB
NID210 ..............argB2 pyrG89 veA1 IS1::PgpdA-TtrpC-argB
NID211 ..............argB2 pyrG89 veA1 IS1::PgpdA-mpaC-TtrpC-argB
NID257 ..............argB2 pyrG89 veA1 IS1::PgpdA-mRFP-TtrpC-argB
FIG. 1. Integration of a general expression cassette into the inte-
gration site IS1, situated between AN6638 and AN6639 on chromo-
some I (represented as a fat black line) by homologous recombination.
The gene-targeting substrate contains six parts: YFG (your favorite
gene), TSI and TSII (targeting sequences I [1,949 bp] and II [1,926
bp]), and the promoter (prom), terminator (term), and marker of
choice. The orientations of genes AN6638 and AN6639 are indicated
by green arrows. The illustration is not drawn to scale.
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USER cloning of lacZ, RFP, and mpaC into USER vectors. E. coli lacZ was
amplified from pWJ1042 (7) using the primers BGHA503 and BGHA504. The
red fluorescent protein gene (RFP) was amplified from pSK800 (28) using the
primers BGHA564 and BGHA565. The P. brevicompactum mpaC coding se-
quence, including introns, was amplified from BAC1E13 (25) using the primers
BGHA296 and BGHA297. Purified PCR products were USER cloned into the
AsiSI/Nb.BtsI USER cassette in pU2111-1, pU2211-1, pU1111-1, and pU1211-1.
PCR-generated sections of plasmids were sequenced (StarSeq, Germany) to
confirm that no mutations were introduced by PCR errors.
A. nidulans strain constructions. Protoplasting and gene-targeting procedures
were performed as described previously (11, 20). Five micrograms of plasmid was
digested either with NotI (argB- and ble-containing constructs) or with SwaI
(pyrG-containing constructs) to liberate the gene-targeting substrate, which was
used for transformation of IBT28738 (using argB as the selection marker) or
IBT29539 (using pyrG as the selection marker). Streak-purified transformants
were grown on 5-FOA medium to select for recombinants where the nkuA locus
was restored to wild type, as described previously (17). All gene-targeting events
were verified by analytical PCR using Taq polymerase (Sigma-Aldrich) and
genomic DNA obtained from individual transformants. A list of primers for
verifying transformants in IS1 can be found in Table S3 of the supplemental
material. The region upstream of the integration events was tested using primer
BGHA163, which anneals upstream of the TS1 sequence, and a primer that
anneals to the inserted promoter (BGHA502 for PgpdA and BGHA267 for
PalcA) (see Fig. S6 in the supplemental material). Similarly, the downstream
region of the integration event was tested using primer BGHA162, which anneals
downstream of the TS2 sequence, and one that anneals to the selectable marker
(BGHA98 for argB and BGHA182 for AFpyrG).
Creation of a point mutation inmpaC. Point mutations in the DSL motif of the
acyl carrier protein (ACP) domain in mpaC were created by using a variation of
the USER fusion method previously described (10). The DSL-to-ASL mutation
was obtained by USER fusing of two PCR fragments generated by primer pairs
(BGHA456 with BGHA297 and BGHA457 with BGHA296, respectively), using
mpaC as template. Simultaneously, the fusion fragment was USER cloned into
the pU1111-1 vector fragment, which was included in the same reaction mixture
(see Results and Discussion for further details). The DSL-to-DAL mutation was
made in the same way except that the two PCR fragments were generated by
primer pairs BGHA458 with BGHA297 and BGHA459 with BGHA296. The two
mutated mpaC genes were inserted into IS1 by the method described above.
Batch fermentation. Batch fermentations of A. nidulans were performed in
2-liter Braun fermentors with a working volume of 1.6 liters and equipped with
two Rushton four-blade disk turbines. The bioreactor was sparged with air, and
the concentrations of carbon dioxide in the exhaust gas were measured in a gas
analyzer. The temperature was maintained at 30°C, and the pH was kept con-
stant at 5.5, controlled by automatic addition of either 2 M NaOH or 2 M HCl.
Agitation and aeration were controlled throughout the cultivations. For inocu-
lation of the bioreactor and germination of spores, the stirring rate was set to 200
rpm and aeration was set to 0.2 liter/min. The bioreactors were inoculated with
spores suspended in 0.9% NaCl to a concentration of 1.5  109/liter. Twelve
hours after inoculation, the stirring rate was increased to 350 rpm and the air
flow was increased to 1.5 liters/min and kept at that level for the remainder of the
process. Statistical analysis of growth rates was performed using simple linear
regression for multireplicate data on natural logarithmic-transformed data, and
comparisons are based on Student’s t test, adopted for linear regression data.
Determination of -galactosidase activity. Assays for -galactosidase activity
were performed using mycelia harvested from batch fermentations in the sta-
tionary phase (45 h after inoculation) containing 5 g (dry weight) of biomass/liter.
Quantification was performed using the o-nitrophenyl--galactopyranoside
method (15) with the following modifications. Mycelia from 1 ml of fermentation
broth were transferred to a 2-ml screw-cap tube containing 250 l glass beads
(0.5-mm diameter), 250 l ice cold Z-buffer (26), and 12.5 l of a 100 mM
4-(2-amino-ethyl)-benzenesulfonyl fluoride hydrochloride solution. The samples
were homogenized by shaking for 30 s at maximum speed in a Fastprep FP120
(Bio 101 Savant). The extraction volumes were increased by addition of 250 l
ice-cold Z-buffer and cleared for cell debris by centrifugation at 10,000  g for
30 min at 4°C. Total protein content in the cleared extract was determined using
the Quant-It protein assay kit (Invitrogen) with the Quibit fluorometer (Invit-
rogen) according to the instructions of the manufacturer.
Fluorescence microscopy. Microscopy was essentially performed as previously
described (23). Images were captured with a cooled Evolution QEi monochrome
digital camera (Media Cybernetics Inc.) mounted on a Nikon Eclipse E1000
camera (Nikon).
RNA isolation and qRT-PCR. A. nidulans total RNA, from four strains grown
under identical conditions (NID127, NID210, NID211, and NID257), was iso-
lated with the Qiagen plant RNeasy kit. Ten micrograms of RNA was DNase I
(Qiagen)-treated prior to cDNA amplification of 1 g of DNase I-treated RNA
samples by using a Phusion RT-PCR kit (Finnzymes) according to the manufac-
turer’s protocol. The subsequent quantitative reverse transcription-PCR (qRT-
PCR) was performed in a Chromo 4 detector/PTC-200 apparatus (MJ Research)
by using SYBR Green JumpStart Taq ReadyMix (Sigma). The A. nidulans actin
gene, actA AN6542, was the internal standard for normalization of expression
levels. The primer combination AN6638-F/AN6638-R was used for AN6638,
AN6639-F/AN6639-R for AN6639, AN6640-F/AN6640-R for AN6640, AN6636-
F/AN6636-R for AN6636, ANactA-F/ANactA-R for actA, and AN10837-F/
AN10837-R for AN10837. All primers are listed in Table S3 of the supplemental
material. Two types of control samples were included for the qPCR: a DNase-
treated RNA sample and a template-free reaction mixture, to test for the primer-
dimer influence on overall fluorescence. The individual cDNA samples were run
both as concentrated samples (1/10 of the cDNA prep) and 10-diluted samples
(1/100). Samples were run in triplicates. The program was 94°C for 2 min and
40 cycles of 94°C for 10 s, 60°C for 15 s, and 72°C for 30 s. A melting curve from
65°C to 95°C with reads every 0.2 min ended the program to evaluate the purity
of the reaction products. The fluorescence threshold values (CT) were deter-
mined by using the OpticonMonitor 3.1 software (MJ Research). The relative
expression levels were approximated based on 2CT, with CT 
CT(normalized)  CT(calibrator), where CT(normalized)  CT(target gene) 
CT(actA).The calibrator CT values are those for the reference strain, NID127.
Chemical characterization of mutants. Three 6-mm-diameter plugs were
taken from each strain and grown as three-point inoculations in the dark at 25°C
for 7 days on YES medium (27). The plugs were transferred to a 2-ml vial, and
1 ml of acetonitrile (ACN) was added. The plugs were placed in an ultrasoni-
cation bath for 60 min. The ACN was filtered and transferred to a new 2-ml clean
vial, in which the organic phase was evaporated to dryness by applying nitrogen
airflow at 30°C. The residues were redissolved ultrasonically for 10 min in 150 l
of an ACN-H2O (1:1, vol/vol) mixture. Samples of 1 to 5 l were analyzed by
high-performance liquid chromatography (HPLC)–UV/Vis by using 15 to 100%
ACN in 20 min on a Luna C18 column (19). HPLC-UV/Vis high-resolution mass
spectrometry (LC-HRMS) analysis was performed with an Agilent 1100 system
(Waldbronn, Germany) equipped with a diode array detector and coupled to an
LCT apparatus (Micromass, Manchester, United Kingdom) equipped with an
electrospray ionization system (18, 19). Separations of 1 to 5 l of sample were
performed on a 100- by 2-mm (inner diameter), 2.6-m Kinetex C18 column
(Phenomenex, Torrance, CA), using a linear water-ACN gradient at a flow rate
of 0.400 ml/min from 10 to 65% ACN within 14 min, then to 100% ACN in 3 min,
followed by a plateau at 100% ACN for 3 min. Both solvents contained 20 mM
formic acid. Samples were analyzed both in ESI and ESI	 modes. For com-
pound identification, each peak was matched against an internal reference stan-
dard database (
800 compounds) (18). 3-Methylorsellinic acid (Ambinter, Paris,
France) and orsellenic acid (Apin Chemicals, Oxon, United Kingdom) were
coanalyzed. Other peaks were tentatively identified by matching data from pre-
vious studies in our lab and searching the accurate mass in the 
13,000 fungal
metabolites reported in Antibase 2009 (12). Here UV-Vis data, fragmentations,
ionization efficiencies in ESI versus ESI	, and retention times were used.
RESULTS AND DISCUSSION
Identification of a genomic insertion site for heterologous
gene expression. An ideal all-around genomic integration site
for characterization of heterologous genes and their products
should accommodate the new genes without interfering with
the fitness of the strain and allow for high and stable expression
levels in a tissue-unspecific manner. To identify such a site, we
exploited the existing transcriptome microarray data of A. ni-
dulans (1), obtained during exponential growth on different
carbon sources, to identify genomic regions that supported
high expression under all the different growth conditions in-
vestigated. One possible site of integration, IS1, which fulfilled
these criteria and is situated 202 bp downstream of AN6638
and 245 bp upstream of AN6639, was selected for further
characterization. To evaluate the usefulness of IS1 as a site for
heterologous expression, we inserted lacZ and RFP into this
locus (NID192 and NID257, respectively) by taking advantage
of the vector set described below. Expression of lacZ from IS1
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was first visualized by growing NID192 on X-Gal-containing
plates. As expected, NID192 colonies were bright blue due to
-galactosidase production, whereas colonies from a reference
strain (NID127), which does not contain lacZ, were pale (Fig.
2A). Importantly, expression of lacZ appeared stable over
time, as the blue appearance of colonies did not change over
time as judged by visual inspection of colonies obtained from
three successive restabbings (data not shown). To examine the
level of protein production, NID192 was grown in MM in
well-controlled bioreactors by using a batch fermentation
setup. Crude protein extracts prepared from NID192 mycelia,
which were harvested in the stationary phase of the fermenta-
tion, converted -nitrophenyl--D-galactoside at a rate of 5.3
mol/min/mg of total protein. This level of activity is similar to
what was obtained by Lubertozzi and Keasling, who inserted
PgpdA::lacZ into three different loci, argB, trpC, and niaD, of
A. nidulans (13). The reference strain, NID127, was analyzed
in parallel and produced no detectable -galactosidase activity
(see Fig. S7 in the supplemental material). Importantly, we
noted that given these experimental conditions the growth
rates of NID192 and NID127 were not significantly different
(P  0.2), indicating that insertion of foreign DNA into IS1
does not impair fitness of the strain in MM. Inspection of
NID257, which expresses RFP, by fluorescence microscopy
revealed easily detectable RFP distributed uniformly through-
out the mycelia (Fig. 2B). Similarly, RFP was also present in
the spores (Fig. 2B), indicating that RFP is expressed from IS1
in a tissue-independent manner. We also investigated whether
inserting an expression cassette into IS1 influenced expression
of the flanking genes, AN6638 and AN6639. The expression
levels of the two genes were determined in a reference strain as
well as in three different strains containing the PgpdA/TtrpC
expression cassette and the argB selection marker. In the three
strains, the cassette contained either nothing, RFP, or mpaC.
Of the two flanking genes, only AN6638, which is located next
to the constitutive promoter PgpdA, was significantly affected
(
2.5-fold increase) in these three strains. To investigate
whether other genes close to this locus were affected by the
presence of an expression cassette in IS1, the same analysis was
performed for AN6636, AN10837, and AN6639. None of these
genes was expressed differently in the three strains containing
an expression cassette in IS1 compared to the reference strain.
The modest effect of gene expression in the IS1 region after
integration of an expression cassette is in agreement with the
finding that the presence of a lacZ expression cassette in IS1 in
a strain does not influence the growth rate. Based on the
combined results of the experiments described above, we con-
clude that the integration site IS1 is useful for integrating novel
genes for their further characterization.
Construction of a flexible USER vector set for gene analysis
of Aspergillus nidulans. To facilitate exploiting IS1 as a conve-
nient expression platform for foreign genes, we constructed a
flexible vector set which allows for easy construction of gene-
targeting substrates for integration of your favorite gene
(YFG) into IS1 by taking advantage of the DNA ligase-free
improved USER cloning system (22). So far, the set comprises
six vectors (Table 2), allowing for integration of YFG into IS1
under the control of either inducible PalcA or constitutive
PgpdA by using either the selectable marker argB, ble, or pyrG.
The latter marker can be recycled after transformation and
used in subsequent experiments, since it is flanked by direct
repeats that allow pyrG to be eliminated by popout recombi-
nation (20). In all vectors, the terminator TtrpC is present
downstream of the YFG integration site.
TABLE 2. Names and descriptions of one-step USER vectors for
inserting YFG into IS1
Vector Marker Promoter Terminator USER cassette/cloning cassette
Integration
site
pU1111-1 argB PgpdA TtrpC AsiSI/Nb.BtsI IS1
pU1211-1 argB PalcA TtrpC AsiSI/Nb.BtsI IS1
pU2111-1 pyrG PgpdA TtrpC AsiSI/Nb.BtsI IS1
pU2211-1 pyrG PalcA TtrpC AsiSI/Nb.BtsI IS1
pU3111-1 blea PgpdA TtrpC AsiSI/Nb.BtsI IS1
pU3211-1 blea PalcA TtrpC AsiSI/Nb.BtsI IS1
a ble confers resistance to the genotoxin bleomycin.
FIG. 2. Expression of -galactosidase and RFP from IS1 in A.
nidulans. (A) To the left are shown the positions of strains on the plate
shown to the right. NID127 is a reference strain, and NID192 contains
PgpdA::lacZ. To the right, strains were stabbed on an X-Gal-contain-
ing plate and incubated for 2 days at 37°C before plates were subjected
to photography. (B) NID257 containing PgpdA::RFP was examined by
bright-field (BF) microscopy and by fluorescence microscopy detecting
RFP, as indicated. The top panels show a full mycelium, the middle
panels show hyphal tips, and the bottom panels show conidia spores.
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By using one (or more) of the vectors in our vector set, YFG
can rapidly be introduced into IS1 in A. nidulans by performing
four simple steps (Fig. 3). In step 1, the gene of interest is PCR
amplified with primers containing the appropriate tails for
USER cloning into the AsiSI/Nb.BtsI USER cassette. In step
2, the PCR fragment is USER cloned into the appropriate
vector; in step 3 the completed gene-targeting substrate con-
taining YFG is released from this vector by restriction enzyme
digestion or by PCR. In step 4, the gene-targeting substrate is
used for transformation of A. nidulans protoplasts. In our
hands, this can be done in less than 48 h, and A. nidulans
transformants are obtained a few days later.
The vector set is designed for optimal flexibility. Hence, in
case other markers, promoters, terminators, or other integra-
tion sites are preferred, the present repertoire of vectors can
easily be expanded, since all parts can be replaced in simple
USER cloning-based reactions. As a guideline for future vec-
tor construction, we present the strategy for building pU2111-1
as a model (see Fig. S5 and, for details, Fig. S1, S2, S3, and S4
in the supplemental material).
Cloning of mpaC from Penicillium brevicompactum and
transformation into A. nidulans. To demonstrate the potential
of the presented USER vector set for heterologus expression
and characterization of YFG in A. nidulans, we decided to
investigate a recently discovered gene cluster from Penicillium
brevicompactum that has been proposed to encode the en-
zymes required for MPA production (25). The mpaC gene in
the cluster consists of 7,745 bp, including introns, and is pre-
dicted to encode a polyketide synthase (PKS) that catalyzes
production of the polyketide 5-MOA, which is believed to be
the first intermediate in MPA biosynthesis (2). The large size
of mpaC makes it well suited to test the robustness of our
USER cloning-based system for cloning and inserting YFG
into IS1. The large mpaC gene was PCR amplified as three
fragments, which were subsequently fused by taking advantage
of the USER fusion technique (10), which allows several PCR
fragments to be merged in a single cloning step. Using this
principle, the entire mpaC gene was readily inserted into the
argB gene containing vectors pU1111-1 and pU1211-1, hence
equipping mpaC with the constitutive PgpdA and inducible
PalcA promoters, respectively. In both cases more than 50% of
the colonies had mpaC inserted between the promoter and
terminator, demonstrating the efficiency of the construction
part of the system. The entire mpaC gene was sequenced for
both constructs, and no PCR-generated errors were observed.
Using the argB marker for selection, the two constructs were
used for transformation of A. nidulans IBT28738 protoplasts.
This strain allows for efficient integration of gene-targeting
substrates by homologous recombination, since the competing
pathway for genomic DNA integration, nonhomologous end
joining, has been transiently eliminated due to a pyrG insertion
in the nkuA locus (17). In agreement with this, a PCR test
demonstrated that the mpaC expression cassette was inte-
grated into IS1 in all transformants analyzed (data not shown).
Finally, selected transformants were grown on medium con-
taining 5-FOA to reconstitute nkuA to avoid any influence of a
defective nkuA gene on further strain characterization (see
reference 17 for details).
FIG. 3. Construction of a gene-targeting substrate designed for integrating an expression cassette into IS1. The example shows construction of
an expression cassette containing YFG flanked by the PgpdA promoter and the TtrpC terminator. A vector fragment with 8-nucleotide
single-stranded DNA overhangs is generated by cutting pU2111-1 simultaneously with restriction endonuclease AsiSI and restriction nicking
endonuclease Nb.BtsI. Note that the two overhangs contain three different nucleotides (represented in pale green and pale purple) to ensure the
directionality of subsequent fragment insertion. A PCR-generated insert fragment containing YFG is generated by primers that are extended at
the 5 ends by a uracil residue (highlighted in magenta), followed by seven nonpriming nucleotides. Treatment of the PCR fragment with USER
enzyme removes uracil residues to generate ends with 8-nucleotide single-stranded DNA overhangs that match the ends of the vector fragment.
Insert and vector fragments are mixed and cotransformed into E. coli, where the two fragments are joined by E. coli-mediated ligation. AsiSI and
Nb.BtsI recognition sequences are marked in light blue and tan, respectively. The illustration is not drawn to scale.
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Introduction of a point mutation in the DSL motif in the
ACP domain of mpaC. Detailed characterization of a gene
product requires simple means to introduce genetic modifica-
tions, like deletions and point mutations. Use of the present
commercially available techniques for introduction of such
modifications in large vectors, like those containing an entire
gene-targeting substrate, constitutes a challenging and tedious
task. By making a slight modification to the USER fusion
technique described above, point mutations and deletions can
easily be introduced in YFG. Hence, if the primer tails used to
merge individual segments of YFG contain the desired point
mutation, defined sequence modifications can be inserted any-
where in a gene (Fig. 4). Similarly, deletions can be introduced
by designing matching USER primer tails, which at the fusion
point will bridge two noncontinuous, but successive, sections of
YFG. Here we have demonstrated the principle of introducing
point mutations into mpaC by using USER cloning to inde-
pendently introduce two alanine substitutions, D1622A and
S1623A, in the conserved DSL motif in the ACP domain of
MpaC. Both substitutions are predicted to impair polyketide
synthase activity. It is known that the phosphopantetheine moi-
ety of coenzyme A binds to the serine in the DSL domain of
PKSs (6), and therefore an S1623A substitution in MpaC is
likely to prevent the phosphopantetheine moiety of coenzyme
A from binding to the serine in the DSL domain. Accordingly,
MpaC cannot be converted from the inactive apo form to the
active holo form in this mutant protein. From studies on other
PKSs it has been found that the negatively charged aspartate in
the DSL motif in the acyl carrier protein domain creates a salt
bridge to the acyltransferase domain, ensuring that these two
domains interact properly (5). Therefore, the D1622A muta-
tion in MpaC is predicted to disrupt MpaC activity. The cre-
ation of the two mpaC mutants was as fast and efficient as
cloning of the wild-type mpaC described above. Both mpaC
variants were verified by sequencing, and no additional PCR-
generated errors were observed. We note that the method is
applicable for introducing several point mutations in different
regions of interest in a single round of cloning, simply by fusing
additional PCR fragments. Specifically, simultaneous construc-
tion of two mutations require the fusion of three PCR frag-
ments, three mutations require the fusion of four PCR frag-
ments, and so on. To this end, we note that presently up to five
fragments have been efficiently fused by USER fusion and that
the upper limit has yet not been delineated (10).
Expression of mpaC in A. nidulans results in 5-methylorsel-
linic acid production. To investigate 5-MOA production in A.
FIG. 4. Method to introduce point mutations in YFG by USER cloning, as exemplified by a mutation in mpaC. (A) Graphical representation
of mpaC. A section of mpaC encoding the region around and including the conserved DSL motif in the ACP domain is presented at the nucleotide
level. The codon targeted for mutation is marked in bold. (B) Annealing positions of primers required for site-directed mutagenesis of the DSL
motif of MpaC are indicated by arrows. The 5 sections of the primers, which are relevant for USER fusion of fragments, are presented as
nucleotides. Red nucleotides in primers BGHA458 and BGHA459 represent the desired mutation. (C) The entire mpaC gene is amplified as two
fragments in two separate PCRs by using the two primer pairs BGHA296 with BGHA459 and BGHA458 with BGHA297 and mpaC as template.
The two fragments are subsequently combined and inserted into an expression vector in a single USER cloning step. The desired mutation is
generated at the fusion point where the two fragments merge via the overlapping tails of the two mutagenic primers BGHA458 and BGHA459.
The illustration is not drawn to scale.
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nidulans, we first analyzed a reference strain, NID210 (in
which AR1 contains argB integrated at IS1) for its ability to
produce 5-MOA. Since 5-MOA is not commercially available,
a reference standard of 3-MOA, which is expected to behave
very similarly to 5-MOA in LC-HRMS analyses, was analyzed.
Since neither 3-MOA nor 5-MOA has previously been re-
ported in A. nidulans, we surprisingly identified a compound
eluting at 4.09 min with an elementary composition identical to
that of both 3- and 5-MOA in the extract (Fig. 5A). However,
since both the retention time and the UV spectrum of this
compound were identical to that of the 3-MOA standard, it
was unambiguously assigned as 3-MOA. Next, a strain contain-
ing the PgpdA::mpaC expression cassette at IS1 (NID211) was
analyzed by LC-HRMS. In contrast to the reference strain,
NID211 produced a compound eluting as a prominent peak at
3.78 min with the mass expected for 5-MOA (Fig. 5A). This
peak contained a unique ion with m/z 181.050, corresponding
to the [M-H] ion of C9H10O4. Moreover, it produced a UV
spectrum (Fig. 5B) that was identical to the previously pub-
lished UV spectrum for 5-MOA (24). We note that NID211,
like the reference strains, also produced the compound eluting
at 4.09 min, supporting that this compound was 3-MOA.
Next we addressed whether the unique compound produced
by NID211 is due to the mpaC gene product or whether it
results from the expression of an endogenous A. nidulans
gene(s) that is accidentally activated by insertion of the
PgpdA::mpaC expression cassette into IS1. To this end, we first
analyzed the two strains expressing PgpdA::mpaC-D1622A
and PgpdA::mpaC-S1623A (NID189 and NID190, respec-
tively). In both cases, no compound eluted at 3.78 min. More-
over, strain NID66, which harbors the expression cassette
PalcA::mpaC inserted at IS1, produced a compound eluting at
3.78, but only when the strain was grown on medium inducing
expression from PalcA (Fig. 5C). Together, the data conclu-
sively demonstrate that mpaC encodes a polyketide synthase
that produces 5-MOA. In addition, since the mpaC gene ex-
pressed in A. nidulans contained its native P. brevicompactum
introns, we conclude that these introns were efficiently re-
moved by the splicing apparatus of A. nidulans.
Concluding remarks. In this report we have presented a
simple USER cloning-based system that allows genes to be
transferred from organisms of interest into the well-character-
ized fungal model A. nidulans for further characterization. As
proof of concept, we firmly demonstrated that mpaC from P.
brevicompactum encodes the PKS responsible for production
of 5-MOA, the first intermediate in MPA production. Impor-
tantly, since the vector set is constructed in a flexible manner,
it can easily be modified to allow specific integration of YFG
into other organisms that support efficient gene targeting, if
desirable. The strategy for gene characterization presented
here is therefore widely applicable and should greatly facilitate
assignment of gene functions in organisms where the genetic
toolbox is poorly developed.
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